Dixon Advisory directors withdraw Premium board nominations
Dixon Advisory directors proposing to be nominated to the Premium Investors board have now withdrawn their consent. The decision follows the announcement of Premium’s capital management plan, which involves a share buy-back scheme and amendments to the listed investment company’s constitution.
Last month a small number of Dixon Advisory shareholders called for a meeting of Premium shareholders to consider amendments to the company’s constitution, as well as the replacement of the current Premium board with Dixon Advisory staff — a result that would allow the new board to wind up the company. The move followed a period during which Premium’s share price did not reflect the net tangible asset (NTA) value of the company’s shares, the discount at one stage growing to 42 per cent.
Dixon Advisory said in a statement that the capital management plan meets the main concerns they raised, and that the proposed plan is in the best interests of shareholders.
Dixon Advisor managing director of strategy Chris Brown said Premium’s proposed off-market and subsequent on-market share buy-backs “will provide significant liquidity to all shareholders at a value close to the underlying NTA value of their shares”.
Premium has put three proposed resolutions to its shareholders: an immediate off-market equal access buy-back of up to 65 per cent of issued capital at a discount of 1.75 to NTA; a subsequent on-market buy-back over the next year of up to 15 per cent issued capital; and amendments to the constitution that will facilitate periodic capital management assessments by shareholders.
The Dixon Advisory directors removing their consent to be nominated will discuss the matter with members in order to secure their agreement to withdraw the meeting request.
Recommended for you
ASIC has permanently banned a former Perth adviser after he made “materially misleading” statements to induce investors.
The Financial Services and Credit Panel has made a written order to a relevant provider after it gave advice regarding non-concessional contributions.
With wealth management M&A appetite only growing stronger, Business Health has outlined the major considerations for buyers and sellers to prevent unintended misalignment between the parties.
Industry body SIAA has said the falling number of financial advisers in Australia is a key issue impacting the attractiveness and investor participation of both public and private markets.
